ArticleJournal of general internal medicine2016
Receipt of Cancer Screening Is a Predictor of Life Expectancy.
Article in Journal of general internal medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial.JAMA internal medicine · 2019Trial
- Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios.Cancers · 2021Article
- Association Between Receipt of Cancer Screening and All-Cause Mortality in Older Adults.JAMA network open · 2021Article
- Use of Lung Cancer Screening With Low-Dose Computed Tomography in the Medicare Population.Mayo Clinic proceedings. Innovations, quality & outcomes · 2019Article
- Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries.Radiology · 2018Article
- Capsule Commentary on Goodwin et al., Receipt of Cancer Screening is a Predictor of Life Expectancy.Journal of general internal medicine · 2016Article
- Cultural Influences on Primary Care Delivery.Journal of general internal medicine · 2016Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
backgroundObtaining cancer screening on patients with limited life expectancy has been proposed as a measure for low quality care for primary care physicians (PCPs). However, administrative data may underestimate life expectancy in patients who undergo screening.
objectiveTo determine the association between receipt of screening mammography or PSA and overall survival.
designRetrospective cohort study from 1/1/1999 to 12/31/2012. Receipt of screening was assessed for 2001-2002 and survival from 1/1/2003 to 12/31/2012. Life expectancy was estimated as of 1/1/03 using a validated algorithm, and was compared to actual survival for men and women, stratified by receipt of cancer screening.
participantsA 5 % sample of Medicare beneficiaries aged 69-90 years as of 1/1/2003 (n = 906,723).
interventionsReceipt of screening mammography in 2001-2002 for women, or a screening PSA test in 2002 for men. MAIN MEASURES: Survival from 1/1/2003 through 12/31/2012. KEY
resultsSubjects were stratified by life expectancy based on age and comorbidity. Within each stratum, the subjects with prior cancer screening had actual median survivals higher than those who were not screened, with differences ranging from 1.7 to 2.1 years for women and 0.9 to 1.1 years for men. In a Cox model, non-receipt of screening in women had an impact on survival (HR = 1.52; 95 % CI = 1.51, 1.54) similar in magnitude to a diagnosis of complicated diabetes or heart failure, and was comparable to uncomplicated diabetes or liver disease in men (HR = 1.23; 1.22, 1.25).
conclusionsReceipt of cancer screening is a powerful marker of health status that is not captured by comorbidity measures in administrative data. Because life expectancy algorithms using administrative data underestimate the life expectancy of patients who undergo screening, they can overestimate the problem of cancer screening in patients with limited life expectancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.